Skip to main content
Premium Trial:

Request an Annual Quote

Syngenta Licenses InforSense Platform for Three Years

NEW YORK, Jan. 25 (GenomeWeb News) - Syngenta has signed a three-year deal to deploy the InforSense software suite throughout its global R&D divisions, InforSense said today.


Syngenta licensed the software suite to build up its bioinformatics platform, InforSense said.


Financial details of the deal were not disclosed.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.